Herpes simplex virus 2 vaccine candidate: Human trials in 2017?
by Press Release from Outbreak News Today on (#29MGE)
Approximately 500 million people around the world are infected with the genital herpes virus known as herpes simplex virus 2 (HSV2). A vaccine that could bring an end to this global pandemic is needed desperately, yet no candidate vaccine has ever performed well in clinical trials. Now scientists in the Perelman School of Medicine at ["]
The post Herpes simplex virus 2 vaccine candidate: Human trials in 2017? appeared first on Outbreak News Today.